US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Gelteq

0.5428

+0.01282.42%

Post-market: 0.5133-0.0295-5.43%19:56 EDT

Volume:202.89K

Turnover:104.36K

Market Cap:6.07M

PE:-1.16

High:0.5540

Open:0.5318

Low:0.5000

Close:0.5300

52wk High:2.01

52wk Low:0.3870

Shares:11.18M

Float Shares:5.15M

Volume Ratio:1.81

T/O Rate:3.94%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.4690

EPS(LYR):-0.4699

ROE:-42.93%

ROA:-17.61%

PB:0.62

PE(LYR):-1.16

Loading ...

Overview Company News Filings

NASDAQ Trade Halt Volatility Trading Pause at 11:27 Am

NASDAQ Trade Halt Volatility Trading Pause at 09:38 Am

Gelteq Limited Advances Clinical Programs and Asia Expansion in First Half of 2026

Gelteq Publishes MD&A for Six Months Ended Dec. 31, 2025

Gelteq signs debt financing deal of up to US$3.5 million with institutional investor

Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs

THOMSON REUTERS

Top Premarket Gainers

MT Newswires Live

Gelteq completes veterinary palatability trials in collaboration with Kemin Industries

Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications

Top Premarket Decliners

MT Newswires Live

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:12 AM

Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion

Gelteq Calls June 19 Special Meeting to Approve Potentially Dilutive Convertible Note Share Issuance

Gelteq announces special shareholder meeting

Gelteq Limited Secures Up to $3.5 Million in Convertible Debt Financing

BRIEF-Gelteq Commences Veterinary Medicine Clinical Trial To Support An FDA Regulatory Pathway

Gelteq starts veterinary clinical trial for antiparasitic drug candidate under FDA pathway

Gelteq Ltd - Targets FDA Regulatory Application for Animal Use in 2026

THOMSON REUTERS

Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway

THOMSON REUTERS

Gelteq secures up to USD 3.5 million strategic debt financing

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/GELS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GELS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GELS\",,,,,undefined,":{"symbol":"GELS","market":"US","secType":"STK","nameCN":"Gelteq","latestPrice":0.5428,"timestamp":1790884800000,"preClose":0.53,"halted":0,"volume":202894,"hourTrading":{"tag":"盘后","latestPrice":0.5133,"preClose":0.5428,"latestTime":"19:56 EDT","volume":2957,"amount":1530.8439,"timestamp":1790898980781,"change":-0.0295,"changeRate":-0.054348,"amplitude":0.068718},"delay":0,"changeRate":0.024150943396226268,"floatShares":5150900,"shares":11183699,"eps":-0.468985,"marketStatus":"Not Yet Opened","change":0.0128,"latestTime":"10-01 16:00:00 EDT","open":0.5318,"high":0.554,"low":0.5,"amount":104363.398356,"amplitude":0.101887,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.468985,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790928000000},"marketStatusCode":0,"adr":0,"listingDate":1710129600000,"exchange":"NASDAQ","adjPreClose":0.53,"preHourTrading":{"tag":"盘前","latestPrice":0.5251,"preClose":0.53,"latestTime":"09:01 EDT","volume":749,"amount":390.82367604,"timestamp":1790859706895,"change":-0.0049,"changeRate":-0.009245,"amplitude":0.018868},"postHourTrading":{"tag":"盘后","latestPrice":0.5133,"preClose":0.5428,"latestTime":"19:56 EDT","volume":2957,"amount":1530.8439,"timestamp":1790898980781,"change":-0.0295,"changeRate":-0.054348,"amplitude":0.068718},"volumeRatio":1.8071},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GELS\",,,,,undefined,":{"symbol":"GELS","floatShares":5150900,"roa":"-17.61%","roe":"-42.93%","lyrEps":-0.46987,"volumeRatio":1.8071,"shares":11183699,"dividePrice":0,"high":0.554,"amplitude":0.101887,"preClose":0.53,"low":0.5,"week52Low":0.387,"pbRate":"0.62","psRate":"18.56","week52High":2.01,"institutionHeld":0,"latestPrice":0.5428,"eps":-0.468985,"divideRate":0,"volume":202894,"delay":0,"ttmEps":-0.468985,"open":0.5318,"prevYearClose":0.8,"prevWeekClose":0.546,"prevMonthClose":0.53,"prevQuarterClose":0.53,"fiveDayClose":0.55,"twentyDayClose":0.7,"sixtyDayClose":0.5597},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GELS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-06-30","symbol":"GELS","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1782792000000,"reportTimeType":"post","actualEps":null},{"date":"2025-11-17","symbol":"GELS","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763370000000,"name":null,"time":"Pre-MKt","dateTimestamp":1763355600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GELS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GELS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GELS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GELS","date":"2026-09-30","current":-1.157393,"percent":0.929314,"low":-21.180883,"twenty":-7.461518,"median":-3.564664,"eighty":-1.565435,"high":-0.877998,"avg":-4.523859,"sd":3.604828,"marketCap":5939659},"quantilePoints":[{"date":"2024-10-24","current":-21.171054,"twenty":-21.176952,"median":-21.171054,"eighty":-21.074172,"marketCap":47190375},{"date":"2024-10-31","current":-10.143847,"twenty":-21.171054,"median":-19.0715,"eighty":-12.552606,"marketCap":22364462},{"date":"2024-11-08","current":-9.685721,"twenty":-21.009583,"median":-10.835689,"eighty":-10.558646,"marketCap":21707572},{"date":"2024-11-15","current":-7.014552,"twenty":-17.133417,"median":-10.60161,"eighty":-9.685721,"marketCap":15289681},{"date":"2024-11-22","current":-6.416922,"twenty":-12.552606,"median":-9.926334,"eighty":-6.79528,"marketCap":14817777},{"date":"2024-11-29","current":-8.190394,"twenty":-11.179072,"median":-9.685721,"eighty":-6.866778,"marketCap":18876150},{"date":"2024-12-06","current":-7.936263,"twenty":-11.904907,"median":-9.791242,"eighty":-6.988572,"marketCap":18122047},{"date":"2024-12-13","current":-12.717639,"twenty":-15.037311,"median":-9.919814,"eighty":-7.370907,"marketCap":28786128},{"date":"2024-12-20","current":-11.5646,"twenty":-14.084739,"median":-10.03509,"eighty":-7.492432,"marketCap":25671564},{"date":"2024-12-27","current":-10.521358,"twenty":-13.396579,"median":-10.430145,"eighty":-7.577881,"marketCap":23217664},{"date":"2025-01-03","current":-10.212771,"twenty":-12.928337,"median":-10.31691,"eighty":-7.75217,"marketCap":22462618},{"date":"2025-01-10","current":-10.447375,"twenty":-12.684632,"median":-10.31691,"eighty":-7.987089,"marketCap":22934522},{"date":"2025-01-17","current":-9.200073,"twenty":-12.390681,"median":-10.143847,"eighty":-8.199443,"marketCap":20291861},{"date":"2025-01-24","current":-12.250467,"twenty":-12.250467,"median":-10.143847,"eighty":-8.235639,"marketCap":27276036},{"date":"2025-01-31","current":-10.587756,"twenty":-11.945486,"median":-10.357767,"eighty":-8.242559,"marketCap":23406426},{"date":"2025-02-07","current":-9.613276,"twenty":-11.838374,"median":-10.143847,"eighty":-8.385479,"marketCap":21424430},{"date":"2025-02-14","current":-9.335065,"twenty":-11.742982,"median":-9.930432,"eighty":-8.685186,"marketCap":20858145},{"date":"2025-02-21","current":-7.993593,"twenty":-11.740961,"median":-9.908289,"eighty":-8.625245,"marketCap":18121104},{"date":"2025-02-28","current":-7.747281,"twenty":-11.599771,"median":-9.805823,"eighty":-8.159414,"marketCap":17177296},{"date":"2025-03-07","current":-5.562716,"twenty":-11.549627,"median":-9.695809,"eighty":-7.723713,"marketCap":12552639},{"date":"2025-03-14","current":-5.584478,"twenty":-11.472534,"median":-9.668507,"eighty":-7.362691,"marketCap":12458259},{"date":"2025-03-21","current":-4.149201,"twenty":-11.277341,"median":-9.487625,"eighty":-6.968767,"marketCap":9261582},{"date":"2025-03-28","current":-4.577543,"twenty":-11.093076,"median":-9.44388,"eighty":-6.473516,"marketCap":10242198},{"date":"2025-04-04","current":-3.851321,"twenty":-10.880164,"median":-9.282379,"eighty":-6.008181,"marketCap":8683029},{"date":"2025-04-11","current":-3.89689,"twenty":-10.716997,"median":-9.200073,"eighty":-5.580126,"marketCap":8588648},{"date":"2025-04-17","current":-3.646379,"twenty":-10.661675,"median":-8.819833,"eighty":-5.383561,"marketCap":8249821},{"date":"2025-04-25","current":-9.652752,"twenty":-10.74667,"median":-8.869441,"eighty":-5.247315,"marketCap":21896334},{"date":"2025-05-02","current":-7.750229,"twenty":-10.661675,"median":-8.814953,"eighty":-5.383561,"marketCap":17554819},{"date":"2025-05-09","current":-6.139277,"twenty":-10.630285,"median":-8.735518,"eighty":-5.474378,"marketCap":13968351},{"date":"2025-05-16","current":-6.99216,"twenty":-10.600957,"median":-8.610931,"eighty":-5.545986,"marketCap":15855966},{"date":"2025-05-23","current":-7.675573,"twenty":-10.57029,"median":-8.239099,"eighty":-5.575773,"marketCap":17460438},{"date":"2025-05-30","current":-6.938057,"twenty":-10.543731,"median":-8.112944,"eighty":-5.636827,"marketCap":15855966},{"date":"2025-06-06","current":-6.975935,"twenty":-10.504597,"median":-7.936263,"eighty":-5.717132,"marketCap":16139108},{"date":"2025-06-13","current":-9.387733,"twenty":-10.504597,"median":-7.964928,"eighty":-5.73826,"marketCap":21707572},{"date":"2025-06-20","current":-7.464332,"twenty":-10.47304,"median":-7.909895,"eighty":-5.7777,"marketCap":17082915},{"date":"2025-06-27","current":-7.644932,"twenty":-10.445748,"median":-7.818055,"eighty":-5.845868,"marketCap":17743581},{"date":"2025-07-03","current":-4.783069,"twenty":-10.439239,"median":-7.807589,"eighty":-5.765943,"marketCap":16233489},{"date":"2025-07-11","current":-5.323861,"twenty":-10.42105,"median":-7.711427,"eighty":-5.562716,"marketCap":18047560},{"date":"2025-07-18","current":-5.389902,"twenty":-10.294483,"median":-7.629441,"eighty":-5.389902,"marketCap":18047560},{"date":"2025-07-25","current":-5.289267,"twenty":-10.212771,"median":-7.530155,"eighty":-5.323861,"marketCap":18047560},{"date":"2025-08-01","current":-5.027113,"twenty":-10.143847,"median":-7.464332,"eighty":-5.289267,"marketCap":16696406},{"date":"2025-08-08","current":-4.542521,"twenty":-9.955308,"median":-7.44921,"eighty":-5.176129,"marketCap":15248741},{"date":"2025-08-15","current":-4.086764,"twenty":-9.934529,"median":-7.347754,"eighty":-5.027113,"marketCap":13704564},{"date":"2025-08-22","current":-3.666074,"twenty":-9.926334,"median":-7.208578,"eighty":-4.89559,"marketCap":12160388},{"date":"2025-08-29","current":-3.7227,"twenty":-9.919814,"median":-7.014552,"eighty":-4.783069,"marketCap":12546432},{"date":"2025-09-05","current":-2.756963,"twenty":-9.901373,"median":-6.99216,"eighty":-4.681949,"marketCap":9265057},{"date":"2025-09-12","current":-4.212457,"twenty":-9.86637,"median":-6.956996,"eighty":-4.570539,"marketCap":14476653},{"date":"2025-09-19","current":-4.123314,"twenty":-9.816413,"median":-6.93514,"eighty":-4.479423,"marketCap":14090608},{"date":"2025-09-26","current":-3.853267,"twenty":-9.744119,"median":-6.895327,"eighty":-4.409409,"marketCap":13028987},{"date":"2025-10-03","current":-3.518907,"twenty":-9.710456,"median":-6.851423,"eighty":-4.336967,"marketCap":11967366},{"date":"2025-10-10","current":-3.878506,"twenty":-9.705099,"median":-6.604267,"eighty":-4.157804,"marketCap":13125498},{"date":"2025-10-17","current":-3.680017,"twenty":-9.689557,"median":-6.556148,"eighty":-4.086764,"marketCap":12353410},{"date":"2025-10-24","current":-3.989256,"twenty":-9.679773,"median":-6.417549,"eighty":-3.986894,"marketCap":13415031},{"date":"2025-10-31","current":-3.336,"twenty":-9.670463,"median":-6.193795,"eighty":-3.910376,"marketCap":11291789},{"date":"2025-11-07","current":-3.092859,"twenty":-9.655903,"median":-6.107898,"eighty":-3.896214,"marketCap":10326679},{"date":"2025-11-14","current":-2.879417,"twenty":-9.621171,"median":-5.948315,"eighty":-3.877357,"marketCap":9747613},{"date":"2025-11-21","current":-1.989951,"twenty":-9.563454,"median":-5.877577,"eighty":-3.852878,"marketCap":8553771},{"date":"2025-11-28","current":-2.664711,"twenty":-9.516787,"median":-5.742874,"eighty":-3.830455,"marketCap":11567943},{"date":"2025-12-05","current":-2.678242,"twenty":-9.486354,"median":-5.584478,"eighty":-3.774196,"marketCap":11782164},{"date":"2025-12-12","current":-2.635623,"twenty":-9.470436,"median":-5.526781,"eighty":-3.720265,"marketCap":11675054},{"date":"2025-12-19","current":-2.092824,"twenty":-9.451613,"median":-5.438383,"eighty":-3.680017,"marketCap":9210439},{"date":"2025-12-26","current":-2.092725,"twenty":-9.421421,"median":-5.404609,"eighty":-3.654535,"marketCap":9318621},{"date":"2026-01-02","current":-1.932469,"twenty":-9.377199,"median":-5.375813,"eighty":-3.628391,"marketCap":8568847},{"date":"2026-01-09","current":-2.081774,"twenty":-9.328311,"median":-5.337925,"eighty":-3.551574,"marketCap":9254354},{"date":"2026-01-16","current":-2.978739,"twenty":-9.293728,"median":-5.253752,"eighty":-3.518165,"marketCap":13281713},{"date":"2026-01-23","current":-2.759102,"twenty":-9.263464,"median":-5.203618,"eighty":-3.433545,"marketCap":12531939},{"date":"2026-01-30","current":-2.326439,"twenty":-9.256997,"median":-5.123533,"eighty":-3.336,"marketCap":10818169},{"date":"2026-02-06","current":-1.851235,"twenty":-9.200073,"median":-5.027113,"eighty":-3.134783,"marketCap":8568847},{"date":"2026-02-13","current":-1.737626,"twenty":-8.919049,"median":-4.916843,"eighty":-3.021963,"marketCap":8190746},{"date":"2026-02-20","current":-1.737839,"twenty":-8.839676,"median":-4.869562,"eighty":-2.91122,"marketCap":8148973},{"date":"2026-02-27","current":-1.698112,"twenty":-8.815929,"median":-4.783485,"eighty":-2.758674,"marketCap":8011872},{"date":"2026-03-06","current":-1.823001,"twenty":-8.796532,"median":-4.768644,"eighty":-2.715595,"marketCap":8461736},{"date":"2026-03-13","current":-1.772518,"twenty":-8.786087,"median":-4.681134,"eighty":-2.663179,"marketCap":8354626},{"date":"2026-03-20","current":-1.692188,"twenty":-8.706052,"median":-4.60497,"eighty":-2.637448,"marketCap":7926183},{"date":"2026-03-27","current":-1.620901,"twenty":-8.68543,"median":-4.494661,"eighty":-2.537995,"marketCap":7433474},{"date":"2026-04-02","current":-1.723102,"twenty":-8.640633,"median":-4.480762,"eighty":-2.446328,"marketCap":7909045},{"date":"2026-04-10","current":-1.751496,"twenty":-8.575816,"median":-4.424826,"eighty":-2.337839,"marketCap":8230377},{"date":"2026-04-17","current":-1.573989,"twenty":-8.45225,"median":-4.407365,"eighty":-2.226702,"marketCap":7497741},{"date":"2026-04-24","current":-1.522918,"twenty":-8.299727,"median":-4.372701,"eighty":-2.168039,"marketCap":7248173},{"date":"2026-05-01","current":-1.446712,"twenty":-8.238407,"median":-4.232685,"eighty":-2.091603,"marketCap":6908633},{"date":"2026-05-08","current":-1.036283,"twenty":-8.208492,"median":-4.154578,"eighty":-2.055295,"marketCap":4991353},{"date":"2026-05-15","current":-1.007013,"twenty":-8.097455,"median":-4.123314,"eighty":-2.00248,"marketCap":4833900},{"date":"2026-05-22","current":-0.986013,"twenty":-8.010354,"median":-4.050455,"eighty":-1.976117,"marketCap":4670021},{"date":"2026-05-29","current":-1.01288,"twenty":-7.970661,"median":-4.001665,"eighty":-1.922102,"marketCap":4818905},{"date":"2026-06-05","current":-1.160257,"twenty":-7.915168,"median":-3.977146,"eighty":-1.839468,"marketCap":5505484},{"date":"2026-06-12","current":-3.525444,"twenty":-7.87613,"median":-3.908596,"eighty":-1.822403,"marketCap":16387920},{"date":"2026-06-18","current":-2.615226,"twenty":-7.855639,"median":-3.898754,"eighty":-1.823001,"marketCap":12210607},{"date":"2026-06-26","current":-1.398176,"twenty":-7.817793,"median":-3.893511,"eighty":-1.816361,"marketCap":6428777},{"date":"2026-07-02","current":-1.43967,"twenty":-7.816743,"median":-3.878506,"eighty":-1.801767,"marketCap":7069298},{"date":"2026-07-10","current":-1.239013,"twenty":-7.807589,"median":-3.869613,"eighty":-1.783455,"marketCap":6092876},{"date":"2026-07-17","current":-1.328283,"twenty":-7.750229,"median":-3.853267,"eighty":-1.752449,"marketCap":6587195},{"date":"2026-07-24","current":-1.682849,"twenty":-7.747281,"median":-3.83658,"eighty":-1.735532,"marketCap":8309484},{"date":"2026-07-31","current":-1.241108,"twenty":-7.689915,"median":-3.826907,"eighty":-1.719508,"marketCap":6162215},{"date":"2026-08-07","current":-1.288383,"twenty":-7.65106,"median":-3.791211,"eighty":-1.707032,"marketCap":6419440},{"date":"2026-08-14","current":-1.299326,"twenty":-7.632539,"median":-3.727191,"eighty":-1.68332,"marketCap":6497726},{"date":"2026-08-21","current":-1.236407,"twenty":-7.609231,"median":-3.716612,"eighty":-1.664824,"marketCap":6235468},{"date":"2026-08-28","current":-1.251365,"twenty":-7.561719,"median":-3.68205,"eighty":-1.62536,"marketCap":6375823},{"date":"2026-09-04","current":-1.959863,"twenty":-7.517586,"median":-3.666074,"eighty":-1.599997,"marketCap":9989275},{"date":"2026-09-11","current":-1.732899,"twenty":-7.504007,"median":-3.650359,"eighty":-1.597231,"marketCap":8802685},{"date":"2026-09-18","current":-1.286991,"twenty":-7.478816,"median":-3.632965,"eighty":-1.574195,"marketCap":6483187},{"date":"2026-09-25","current":-1.23816,"twenty":-7.462872,"median":-3.589223,"eighty":-1.571122,"marketCap":6151031},{"date":"2026-09-30","current":-1.205844,"twenty":-7.461518,"median":-3.564664,"eighty":-1.565435,"marketCap":5939659}],"updateTime":1790921474109},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GELS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669231411","title":"NASDAQ Trade Halt Volatility Trading Pause at 11:27 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2669231411","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669231411?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:27","pubTimestamp":1790090865,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 11:27 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nAQN2MKBFV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GELS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664877456","title":"NASDAQ Trade Halt Volatility Trading Pause at 09:38 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2664877456","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664877456?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:38","pubTimestamp":1788442709,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 09:38 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nAQN2MHWB9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GELS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648591560","title":"Gelteq Limited Advances Clinical Programs and Asia Expansion in First Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2648591560","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648591560?lang=en_us&edition=fundamental","pubTime":"2026-07-01 05:53","pubTimestamp":1782856439,"startTime":"0","endTime":"0","summary":"Gelteq Limited ( ($GELS) ) has issued an update. On June 30, 2026, Gelteq Limited filed a Form 6-K reporting unaudited financial results for the si...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gelteq-limited-advances-clinical-programs-and-asia-expansion-in-first-half-of-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gelteq-limited-advances-clinical-programs-and-asia-expansion-in-first-half-of-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","GELS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648466567","title":"Gelteq Publishes MD&A for Six Months Ended Dec. 31, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2648466567","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648466567?lang=en_us&edition=fundamental","pubTime":"2026-07-01 05:30","pubTimestamp":1782855040,"startTime":"0","endTime":"0","summary":"Gelteq publishes MD&A for six months ended Dec. 31, 2025Gelteq published its MD&A for the six months ended Dec. 31, 2025, highlighting pipeline expansion across pharmaceutical, animal health, consumer","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL7YKc6v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GELS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644746546","title":"Gelteq signs debt financing deal of up to US$3.5 million with institutional investor","url":"https://stock-news.laohu8.com/highlight/detail?id=2644746546","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644746546?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:31","pubTimestamp":1781699477,"startTime":"0","endTime":"0","summary":"Gelteq signed a strategic debt financing facility of up to USD 3.5 million with an institutional investor to fund clinical programs, commercialization.USD 1 million funded at closing via a convertible promissory note; a further USD 2.5 million contingent on shareholder approval.Shareholder vote scheduled for June 18, 2026; the financing has no repayment due for at least six months from the initial closing.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL3f7lVh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","SG9999014039.USD","BK4112","IE00BKPKM429.USD","SG9999014021.USD","GELS","LU2210150020.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","BK4007","LU0314104364.USD","BK4585","IE00BN0W2T93.GBP","NDAQ","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4588","LU2210149790.SGD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644746386","title":"Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2644746386","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644746386?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:30","pubTimestamp":1781699401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nTUA3KP856:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GELS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643702572","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2643702572","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643702572?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:16","pubTimestamp":1781522170,"startTime":"0","endTime":"0","summary":"FreeCast  shares were up 259% in Monday premarket activity, continuing from a 141% rally in the previous session.VS Media  stock was 81% higher, adding to a 52% rise in the earlier session.Paranovus Entertainment  shares were up 62%, recovering from a 28% loss in the previous session.Gelteq  stock was 60% higher, rebounding from a 35% decline in the earlier session.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PAVS","CAST","BK4108","VSME","BK4007","GELS","BK4183","BK4077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643294904","title":"Gelteq completes veterinary palatability trials in collaboration with Kemin Industries","url":"https://stock-news.laohu8.com/highlight/detail?id=2643294904","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643294904?lang=en_us&edition=fundamental","pubTime":"2026-06-13 00:30","pubTimestamp":1781281822,"startTime":"0","endTime":"0","summary":"Gelteq completed veterinary palatability trials with Kemin Industries to optimize flavor profiles for products using its Gelteq gel-based delivery platform.Trial results showed strong canine acceptance, including effective masking of bitter compounds, supporting potential veterinary pharmaceutical use.Data is set to guide future animal-health formulation work, study design, product optimization, partnership talks across the veterinary therapeutics market.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nNDL87yGk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU0314104364.USD","LU2210149790.SGD","LU2210150020.SGD","SG9999014039.USD","SG9999014005.SGD","BK4585","BK4588","BK4007","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","SG9999014013.SGD","SG9999014021.USD","NDAQ","LU2095319765.USD","IE00BN0W2W23.USD","BK4112","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","GELS","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643944122","title":"Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications","url":"https://stock-news.laohu8.com/highlight/detail?id=2643944122","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643944122?lang=en_us&edition=fundamental","pubTime":"2026-06-13 00:30","pubTimestamp":1781281800,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia, June  12, 2026  (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”) today announced the successful completion of its veterinary palatability trials conducted in collab","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/12/3311216/0/en/Gelteq-Successfully-Completes-Veterinary-Palatability-Trials-with-Kemin-Further-Validating-Gelteq-Technology-for-Animal-Health-Applications.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GELS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642260521","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2642260521","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642260521?lang=en_us&edition=fundamental","pubTime":"2026-06-12 19:39","pubTimestamp":1781264349,"startTime":"0","endTime":"0","summary":"Gelteq  shares were down 33% in premarket activity Friday, following a 197% gain in the previous session.Sensus Healthcare  stock was down 26% after closing Thursday with a 3.9% decline.Pop Culture Group  shares were 20% lower, following a 31% loss in the prior session.Smith Micro Software  shares were down 20%, following a 27% gain Thursday.Sleep Number  stock was down 19% after the company agreed to combine with Sleep Country Canada under an asset purchase agreement and launched a voluntary Chapter 11 sale process to facilitate the transaction.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SMSI","BK4082","BK4023","BK4539","CPOP","BK4178","SRTS","BK4108","SNBR","GELS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642323876","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 11:12 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2642323876","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642323876?lang=en_us&edition=fundamental","pubTime":"2026-06-11 23:12","pubTimestamp":1781190756,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 11:12 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nAQN2M36NF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GELS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640150744","title":"Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2640150744","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640150744?lang=en_us&edition=fundamental","pubTime":"2026-06-04 21:08","pubTimestamp":1780578480,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia, June  04, 2026  (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq”) today announced the establishment of a new Gelteq Center of Excellence in Guangdong Province, China. The Gelteq Cent","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/04/3306832/0/en/Gelteq-Establishes-Center-of-Excellence-in-China-to-Accelerate-Product-Development-and-Commercial-Expansion.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAQC","GELS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640925087","title":"Gelteq Calls June 19 Special Meeting to Approve Potentially Dilutive Convertible Note Share Issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=2640925087","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640925087?lang=en_us&edition=fundamental","pubTime":"2026-06-03 04:28","pubTimestamp":1780432101,"startTime":"0","endTime":"0","summary":"Gelteq Limited ( ($GELS) ) has provided an announcement. On May 26, 2026, Gelteq Limited published a notice and explanatory statement for a special...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gelteq-calls-june-19-special-meeting-to-approve-potentially-dilutive-convertible-note-share-issuance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gelteq-calls-june-19-special-meeting-to-approve-potentially-dilutive-convertible-note-share-issuance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","GELS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640923225","title":"Gelteq announces special shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2640923225","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640923225?lang=en_us&edition=fundamental","pubTime":"2026-06-03 04:08","pubTimestamp":1780430894,"startTime":"0","endTime":"0","summary":"Gelteq will hold a special shareholder meeting in Clayton, Victoria on June 19, 2026.Investors will vote on authorizing share issuance tied to convertible notes, including shares issued on conversion or redemption.The approval would let the company issue shares for amounts due under the convertible notes, including principal and interest.The notice cites an illustrative maximum of 8,908,548 shares that could be issued under the convertible notes’ terms.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gelteq Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 02, 2026, and is solely r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL30NZmF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GELS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638752891","title":"Gelteq Limited Secures Up to $3.5 Million in Convertible Debt Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2638752891","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638752891?lang=en_us&edition=fundamental","pubTime":"2026-05-27 04:29","pubTimestamp":1779827347,"startTime":"0","endTime":"0","summary":"Gelteq Limited ( ($GELS) ) has provided an update. On May 7, 2026, Gelteq Limited entered into a securities purchase agreement with an institutiona...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gelteq-limited-secures-up-to-3-5-million-in-convertible-debt-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gelteq-limited-secures-up-to-3-5-million-in-convertible-debt-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GELS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636384200","title":"BRIEF-Gelteq Commences Veterinary Medicine Clinical Trial To Support An FDA Regulatory Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2636384200","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636384200?lang=en_us&edition=fundamental","pubTime":"2026-05-20 20:44","pubTimestamp":1779281057,"startTime":"0","endTime":"0","summary":"BRIEF-Gelteq Commences Veterinary Medicine Clinical Trial To Support An FDA Regulatory PathwayMay 20 (Reuters) - Gelteq Ltd GELS.O:GELTEQ COMMENCES VETERINARY MEDICINE CLINICAL TRIAL TO SUPPORT AN FDA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nTUA3GLPV5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GELS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636844648","title":"Gelteq starts veterinary clinical trial for antiparasitic drug candidate under FDA pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2636844648","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636844648?lang=en_us&edition=fundamental","pubTime":"2026-05-20 20:03","pubTimestamp":1779278582,"startTime":"0","endTime":"0","summary":"Gelteq started its first veterinary clinical trial for an antiparasitic drug candidate using its Gelteq technology.Results have not been presented; the study is intended to generate data for a planned FDA animal-use regulatory submission later in 2026.The trial is designed to support the product’s safety and performance case, positioning the program for a potential entry into the veterinary pharmaceutical market.The company framed the move as part of a dual-track strategy that pairs longer-term drug development with near-term revenue from its nutraceutical business.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDL4h3NSB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00BKPKM429.USD","GELS","IE00B3QW5Z07.USD","SG9999014005.SGD","SG9999014021.USD","LU2095319765.USD","LU2210149790.SGD","SG9999014013.SGD","BK4585","BK4007","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00B64PRP62.GBP","LU2210150020.SGD","IE00BN0W2T93.GBP","BK4112","LU0314104364.USD","IE00BGHQF748.EUR","BK4588","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636844316","title":"Gelteq Ltd - Targets FDA Regulatory Application for Animal Use in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2636844316","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636844316?lang=en_us&edition=fundamental","pubTime":"2026-05-20 20:00","pubTimestamp":1779278404,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nTUA3GLPV5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","GELS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636359844","title":"Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2636359844","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636359844?lang=en_us&edition=fundamental","pubTime":"2026-05-20 20:00","pubTimestamp":1779278404,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nTUA3GLPV5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GELS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634621601","title":"Gelteq secures up to USD 3.5 million strategic debt financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2634621601","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634621601?lang=en_us&edition=fundamental","pubTime":"2026-05-12 20:04","pubTimestamp":1778587459,"startTime":"0","endTime":"0","summary":"Gelteq secured strategic debt financing of up to USD 3.5 million to fund commercialization, expand clinical trial activity, support revenue growth.USD 1 million to be funded at closing; additional USD 2.5 million contingent on shareholder approval targeted for June 2026.Financing includes no repayments for at least six months from closing, extending near-term liquidity runway during commercialization push.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL5v2Nys:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00BN0W2W23.USD","SG9999014013.SGD","NDAQ","IE00BN0W2T93.GBP","GELS","IE00BN0W2V16.EUR","BK4007","IE00BKPKM429.USD","LU2210150020.SGD","BK4588","LU2210149790.SGD","LU0314104364.USD","BK4112","IE00B64PRP62.GBP","SG9999014039.USD","IE00BGHQF748.EUR","SG9999014021.USD","BK4585","SG9999014005.SGD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}]}}